Envista Holdings Corp
NVST20.462USD
-0.368-1.77%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
3.41BCap. mercado
PérdidaP/E TTM
Más Datos de Envista Holdings Corp Compañía
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
Información de la empresa
Símbolo de cotizaciónNVST
Nombre de la empresaEnvista Holdings Corp
Fecha de salida a bolsaSep 18, 2019
Director ejecutivoMr. Paul A. Keel
Número de empleados12300
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 18
Dirección200 S. Kraemer Blvd., Bldg. E
CiudadBREA
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal92821
Teléfono17148175418
Sitio Webhttps://envistaco.com/en
Símbolo de cotizaciónNVST
Fecha de salida a bolsaSep 18, 2019
Director ejecutivoMr. Paul A. Keel
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.42K
-12.76%
Ms. Barbara B. Hulit
Ms. Barbara B. Hulit
Independent Director
Independent Director
79.82K
+15.06%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
55.74K
+22.64%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
55.74K
+22.64%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+30.53%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+31.51%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
41.98K
-4.05%
Mr. J. Andrew Pierce
Mr. J. Andrew Pierce
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.42K
-12.76%
Ms. Barbara B. Hulit
Ms. Barbara B. Hulit
Independent Director
Independent Director
79.82K
+15.06%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
55.74K
+22.64%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
55.74K
+22.64%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+26.02%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+26.03%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Northern America
324.40M
52.59%
Western Europe
143.30M
23.23%
Emerging markets
118.80M
19.26%
Other developed markets
30.40M
4.93%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
9.28%
Ariel Investments, LLC
7.31%
Atlanta Capital Management Company, L.L.C.
7.31%
Dimensional Fund Advisors, L.P.
5.52%
Other
60.34%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
10.24%
BlackRock Institutional Trust Company, N.A.
9.28%
Ariel Investments, LLC
7.31%
Atlanta Capital Management Company, L.L.C.
7.31%
Dimensional Fund Advisors, L.P.
5.52%
Other
60.34%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
58.23%
Investment Advisor/Hedge Fund
45.40%
Hedge Fund
8.82%
Research Firm
1.42%
Pension Fund
1.41%
Sovereign Wealth Fund
1.21%
Bank and Trust
0.61%
Individual Investor
0.55%
Family Office
0.05%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
734
200.23M
118.14%
-35.42M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
2023Q3
779
181.32M
105.90%
-24.06M
2023Q2
772
187.89M
114.71%
-18.52M
2023Q1
783
191.23M
116.82%
-14.97M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
17.02M
10.04%
-218.34K
-1.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
15.43M
9.1%
+235.82K
+1.55%
Mar 31, 2025
Ariel Investments, LLC
12.14M
7.17%
+85.12K
+0.71%
Mar 31, 2025
Atlanta Capital Management Company, L.L.C.
12.14M
7.16%
+242.93K
+2.04%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.39M
4.95%
+1.63M
+24.03%
Mar 31, 2025
Harris Associates L.P.
8.68M
5.12%
-740.06K
-7.86%
Mar 31, 2025
Franklin Mutual Advisers, LLC
7.67M
4.52%
+817.48K
+11.93%
Mar 31, 2025
American Century Investment Management, Inc.
6.35M
3.75%
-552.57K
-8.00%
Mar 31, 2025
State Street Global Advisors (US)
5.68M
3.35%
+33.13K
+0.59%
Mar 31, 2025
Victory Capital Management Inc.
5.44M
3.21%
+3.35M
+161.26%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
SPDR S&P Health Care Equipment ETF
1.85%
Schwab Ariel Opportunities ETF
1.24%
Royce Quant Small-Cap Quality Value ETF
0.56%
JPMorgan Fundamental Data Science Mid Core ETF
0.55%
Pacer US Small Cap Cash Cows ETF
0.38%
iShares U.S. Medical Devices ETF
0.38%
Gotham 1000 Value ETF
0.36%
VictoryShares US Small Mid Cap Value Momentum ETF
0.32%
Global X US Cash Flow Kings 100 ETF
0.32%
DFA Dimensional US Small Cap Value ETF
0.26%
Ver más
SPDR S&P Health Care Equipment ETF
Proporción1.85%
Schwab Ariel Opportunities ETF
Proporción1.24%
Royce Quant Small-Cap Quality Value ETF
Proporción0.56%
JPMorgan Fundamental Data Science Mid Core ETF
Proporción0.55%
Pacer US Small Cap Cash Cows ETF
Proporción0.38%
iShares U.S. Medical Devices ETF
Proporción0.38%
Gotham 1000 Value ETF
Proporción0.36%
VictoryShares US Small Mid Cap Value Momentum ETF
Proporción0.32%
Global X US Cash Flow Kings 100 ETF
Proporción0.32%
DFA Dimensional US Small Cap Value ETF
Proporción0.26%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
